Stay updated on TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial

Sign up to get notified when there's something new on the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added detailed primary objectives (PFS/OS) and endpoint definitions (ORR, DoR, DCR, PFS, OS) along with TROP2 NMR assessment and IPD data-sharing information. Removed or altered several earlier endpoint definitions, time frames, and explicit eligibility criteria.
    Difference
    0.7%
    Check dated 2026-02-24T09:21:13.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 was removed, a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-17T01:22:54.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.1 and the government funding notice and Revision: v3.4.0 have been removed.
    Difference
    0.1%
    Check dated 2026-02-09T22:52:51.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Site-wide notice informs users that information may not be up to date due to a lapse in government funding and that the NIH Clinical Center is open, with operating-status updates linked. This change does not affect the study content, eligibility criteria, or trial results on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-02T21:02:41.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated page metadata to include Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. Removed older metadata fields Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-26T20:37:24.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Added Last Update Posted (Estimated) and Revision: v3.3.4; removed Last Update Posted and Revision: v3.3.3 in the Study Record Dates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-19T15:42:42.000Z thumbnail image

Stay in the know with updates to TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page.